Transcription factor SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in several tumors, such as ovarian and pancreatic cancer, following a different and independent pathway from that of TF-PAR2-VEGF [14, 35]. This evidence concerns the gene F2RL1 and familial pancreatic carcinoma.